None of that documentation carried Ball’s name into the published scientific literature. When she died without having published, the work existed in institutional knowledge without a named author. Dean had access to that institutional knowledge. Hollmann also had access, but Hollmann was a physician, not a chemist; his publication credits in the medical literature did not substitute for a chemistry publication attributing the method to its developer.
The absence of a thesis or paper under Ball’s name on the chaulmoogra work was not an oversight on her part during her lifetime — she was still developing and completing the research when she became ill. It was an absence produced by her death at twenty-four, before she had the opportunity to put her name to what she had done.
—
## Kalaupapa and the Stakes of a Treatment
The Kalaupapa settlement on Molokai stands as the clearest measure of what an effective leprosy treatment actually meant in human terms. Between 1866 and 1969, more than eight thousand people were forcibly removed from their families and communities and sent there under laws that treated leprosy diagnosis as sufficient grounds for indefinite confinement. The majority of those exiled were Native Hawaiians.
The process of removal was administered by the Hawaiian Board of Health. It could be triggered by a single diagnosis. Patients had no guaranteed right to appeal, no defined end to their confinement, no mechanism for release short of a determination that they were no longer infectious — a determination that, before an effective treatment existed, was rarely made. Children diagnosed with leprosy were separated from parents. Parents diagnosed were separated from children. The separation was not temporary; it was understood by all parties involved to be potentially permanent.
